Recent advances in innovative magnetic nanomaterials for cancer theranostics / Sudip Mukherjee.

By: Mukherjee, Sudip [author.]Contributor(s): Institute of Physics (Great Britain) [publisher.]Material type: TextTextSeries: IOP (Series)Release 6 | IOP expanding physics | IOP series in photomedicine and biophotonicsPublisher: Bristol [England] (Temple Circus, Temple Way, Bristol BS1 6HG, UK) : IOP Publishing, [2019]Description: 1 online resource (various pagings) : illustrations (some color)Content type: text Media type: electronic Carrier type: online resourceISBN: 9781643277868 ebookSubject(s): Cancer -- Diagnosis | Cancer -- Treatment | Nanostructured materials -- Magnetic properties | Nanostructured materials -- Therapeutic use | Biomedical engineering | Neoplasms -- therapy | Neoplasms -- diagnosis | Magnetite Nanoparticles -- therapeutic use | Nanostructures -- therapeutic use | Biosensing Techniques | Nursing specialties | MEDICAL / Nursing / Oncology & CancerAdditional physical formats: Print version:: No titleDDC classification: 616.3945 LOC classification: RM865 .M857 2019ebNLM classification: QZ 200Online resources: e-book Full-text access Also available in print.
Contents:
1. Introduction -- 1.1. Cancer and statistics -- 1.2. Conventional therapies for cancer and their limitations -- 1.3. Alternative theranostics strategy: nanomedicine -- 1.4. Magnetic nanoparticles and cancer theranostics
2. Magnetic iron oxide nanoparticles: types, synthesis and characterization -- 2.1. Common types of magnetic nanomaterials and their synthesis -- 2.2. Characterization techniques -- 2.3. Multilayer concept
3. Magnetic nanoparticles for cancer diagnostics -- 3.1. MRI -- 3.2. Multimodal imaging -- 3.3. Biosensors -- 3.4. Cell labeling and monitoring of cancer treatments
4. Magnetic iron oxide based nanoparticles for cancer therapeutics -- 4.1. Drug delivery -- 4.2. Magnetic hyperthermia -- 4.3. Photothermal ablation -- 4.4. Photodynamic therapy (PDT) -- 4.5. MNPs as anti-cancer agent -- 4.6. MNPs in cancer immu
5. Safety of magnetic iron oxide nanomaterials, challenges, future scope and conclusion -- 5.1. Pharmacokinetics, biodistribution, toxicity -- 5.2. Targeting -- 5.3. Magnetic nanoparticles as FDA approved or in clinical trials -- 5.4. Challenges
Abstract: In this book, cancer theranostics applications of magnetic iron oxide nanoparticles are overviewed in detail. Moreover, their synthesis, characterization, multifunctionality, disease targeting, biodistribution, pharmacokinetics and toxicity have
Item type Current library Collection Call number Copy number Status Date due Barcode
E-Books MEF eKitap Kütüphanesi
IOP Science eBook - EBA RM865 .M857 2019eb (Browse shelf (Opens below)) Available IOP_20210173

"Version: 20191001"--Title page verso.

Includes bibliographical references.

1. Introduction -- 1.1. Cancer and statistics -- 1.2. Conventional therapies for cancer and their limitations -- 1.3. Alternative theranostics strategy: nanomedicine -- 1.4. Magnetic nanoparticles and cancer theranostics

2. Magnetic iron oxide nanoparticles: types, synthesis and characterization -- 2.1. Common types of magnetic nanomaterials and their synthesis -- 2.2. Characterization techniques -- 2.3. Multilayer concept

3. Magnetic nanoparticles for cancer diagnostics -- 3.1. MRI -- 3.2. Multimodal imaging -- 3.3. Biosensors -- 3.4. Cell labeling and monitoring of cancer treatments

4. Magnetic iron oxide based nanoparticles for cancer therapeutics -- 4.1. Drug delivery -- 4.2. Magnetic hyperthermia -- 4.3. Photothermal ablation -- 4.4. Photodynamic therapy (PDT) -- 4.5. MNPs as anti-cancer agent -- 4.6. MNPs in cancer immu

5. Safety of magnetic iron oxide nanomaterials, challenges, future scope and conclusion -- 5.1. Pharmacokinetics, biodistribution, toxicity -- 5.2. Targeting -- 5.3. Magnetic nanoparticles as FDA approved or in clinical trials -- 5.4. Challenges

In this book, cancer theranostics applications of magnetic iron oxide nanoparticles are overviewed in detail. Moreover, their synthesis, characterization, multifunctionality, disease targeting, biodistribution, pharmacokinetics and toxicity have

Professional and scholarly.

Also available in print.

Mode of access: World Wide Web.

System requirements: Adobe Acrobat Reader, EPUB reader, or Kindle reader.

Sudip Mukherjee, PhD, AMRSC is a postdoctoral research associate at the department of bio-engineering at Rice University. His research is involved in the development of advanced nano/bio materials for drug delivery in cancer theranostics, immuno

Title from PDF title page (viewed on November 18, 2019).